2Bone R C. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)[J]. Ann Intern Med, 1996,125: 680-687.
3Bone R C. Sir isaac new ton: sepsis, SIRS, and CARS[J].Crit Care Med, 1996, 24 (7):1125-1128.
4Sylvia knapp, Sebastien Gibot, Alex de Vos, et al.Cutting edges: Expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia[J].J Immunol, 2004, 173(12): 7131-7134.
5Lee J I, Burckart GJ. Nuclear facto r kappa B: important transcription factor and therapeutic target[J].J Clin Pharmacol, 1998, 38(11):981 - 993.
6Angele MK, Smail N, Ayala A, et al. L-arginine: a unique amino acid for restoring the depressed macrophage functions after trauma- hemorrhage[J].J Trauma,1999,46(1):34- 41.
7Zellweger R, Wichmann MW, Ayala A and Chaudry IH. Metoclopramide: a novel and safe immunomodulating agent for restoring the depressed maerophage immune function after hemorrhage[J].J Trauma,1998,44:70- 77.
8Gismondo MR, Dragon L, Fassina MC, et al. Immune stimulating effect of oral glutamine[J].Dig Dis Sci, 1998,43(8):1752- 1754.
1Tiansheng S,Xiaobin C,Zhi L,et al.ls damage control orthopedics essential for the management of bilateral femoral fractures associated or complicated with shock? An animal study[J]J Trauma, 2009,67(6) : 1402-1411.
2Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985)."APACHE II: a severity of disease classification system"[J]. Critical Care Medicine, 1985,13(10):818-29.
